[Present status of retrolental fibroplasia in France].
A national survey showed that retrolental fibroplasia still exists in France, as it does in other countries of the world. Retrolental fibroplasia is a condition that principally affects low birth weight premature babies in whom oxygen therapy has not been adequately controlled. The premature babies who have apnaeic attacks are most risk. Strict control of all oxygen therapy, preferably using continuous monitoring techniques together with other changes in the methods of treatment should reduce the incidence of this condition.
D001049:Apnea / Q000188:drug therapy; D001835:Body Weight; D005602:France; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy; D010100:Oxygen / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D012178:Retinopathy of Prematurity / Q000453:epidemiology / Q000209:etiology* / Q000378:metabolism
D010100:Oxygen
Actualité de la fibroplasie rétrolentale en France.